BHC:CC News and Press, Bausch Health Companies Inc. From 10/10/25

2025-10-10 17:18:54 ET Shares of biopharmaceutical concern Monopar Therapeutics Inc. ( MNPR ) have had an absolutely massive surge in the past year after being left for dead with cash of $7.1 million and a market cap under $9 million. Its acquisition of Wilson disease candidate ALXN-184...

LAVAL, QC / ACCESS Newswire / October 9, 2025 / Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the results of the special meeting of shareholders held on October 7, 2025 (the "Shareholders Meeting"). At the Shareholders Meeting, shareholders of the Company app...

2025-10-04 09:59:31 ET More on Pfizer, VanEck Pharmaceutical ETF, etc. Why Eli Lilly Is The Lion's Share Of My Portfolio PPH: The Big Pharma ETF Pfizer: The Long Suffering Is Finally Over (Rating Upgrade) INCY and ABBV lead S&P 500 healthcare gainers in Q...

The Balancing Act airing on Lifetime will showcase how innovative treatments Thermage ® FLX, Clear + Brilliant ® , and Fraxel FTX ™ offer energy-based treatment options that help maintain a youthful appearance while enhancing natural beauty. LAVAL, QC / ACCESS Newswire /...

LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss r...

Designed for dental professionals, OraTalks connects leading voices with insights to spark meaningful dialogue. Nine-episode inaugural season hosted by industry thought leader Melissa K. Turner, BASDH, RDHEP, EFDA, CHO. Candid conversations with leading clinicians on the trends shap...

2025-09-23 21:03:04 ET This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s 13F stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 08/14/2025. Please visit our Tracking John ...

2025-09-23 14:17:43 ET More on Teva Pharmaceutical, Bausch Health Companies Olanzapine LAI (TEV-'749) Phase 3 SOLARIS Data Presentation Bausch Health: Repricing Continues As Deleveraging Gains Traction Teva Pharmaceutical Industries Limited (TEVA) Presents At Morgan ...

Stocks edged lower on Tuesday as investors took in profits and looked to a highly-awaited Federal Reserve meeting. The Dow Jones Industrials sank 111.81 points to 45,771.64. The S&P 500 retreated 10.33 points from Monday’s record high to 6,604.95 The tech-heavy NASDAQ index...

2025-09-11 12:04:32 ET Investment Thesis Read the full article on Seeking Alpha For further details see: Bausch Health: Repricing Continues As Deleveraging Gains Traction